Medical Condition News

RSS

4SC to present development of resminostat and preclinical drug candidates at EORTC-NCI-AACR symposium

4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that it will present four posters and respective abstracts that highlight the development of its lead oncology compound resminostat and several preclinical drug candidates at the 22nd EORTC-NCI-AACR symposium from 16 - 19 November, 2010 in Berlin, Germany.

16 Nov 2010

Study finds two-thirds of asthma patients take combined ICS/LABA treatment

Despite national guidelines recommending that inhaled corticosteroid (ICS) be used alone as the preferred treatment for patients with mild persistent asthma, a new study finds that nearly two-thirds of these patients are taking more costly drugs that combine an ICS and a long-acting beta agonist (LABA) with no apparent additional clinical benefit noted based on pharmacy and medical claims.

16 Nov 2010

Merrion prepares Phase III study for Orazol in breast cancer treatment

After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.

16 Nov 2010

Iron in plaque may predict risk of myocardial infarction

Plaque in a heart artery looks threatening, but cardiologists know that many of these buildups will not erupt, dislodge and block a vessel, causing a heart attack that can be fatal. Some will, however, and the challenge is to figure out atherosclerotic plaque that is dangerous and treat or remove it.

16 Nov 2010

Inconsistent food labels contribute to consumer uncertainty about appropriate food intake

People are easily fooled when it comes to food labels, and will eat more of something if they believe it's a "small" portion, according to a new study in the Journal of Consumer Research.

16 Nov 2010

Study finds significant variability in CPR quality between day and night

CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day, according to a new University of Pennsylvania School of Medicine study that will be presented at the American Heart Association's annual Scientific Sessions on November 14.

16 Nov 2010

IFPA announces winner of Under the Spotlight Award for psoriasis documentary

125 million people worldwide suffer from psoriasis and the hardships this difficult disease brings. Today, on the International Day of Tolerance we are very proud to announce the winner of the 1st Under the Spotlight Award for Best International Documentary on Psoriasis.

16 Nov 2010

Canadian government announces new research initiative on childhood obesity

The Honourable Leona Aglukkaq, Minister of Health, today announced new initiatives for research on physical activity and childhood obesity through the Canadian Institutes of Health Research (CIHR).

16 Nov 2010

Handwriting problems in autistic children likely to continue into teenage years: Study

A new study suggests that the handwriting problems that affect children with autism are likely to continue into their teenage years.

16 Nov 2010

Health researchers to address mental health concerns at world conference

More than 500 mental health researchers, practitioners, and advocates representing over 40 countries will gather for the Sixth World Conference on the Promotion of Mental Health and Prevention of Mental and Behavioral Disorders, November 17–19, 2010, at the Omni Shoreham Hotel in Washington, D.C. With the theme Addressing Imbalances: Promoting Equity in Mental Health, the conference will focus on inequalities in care, research, and practice in ways that protect the most vulnerable.

16 Nov 2010

New high-sensitive blood test may help predict risk of heart failure in older people

Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.

16 Nov 2010

Children's Hospital pediatric immunologist collaborates with European gene therapy researchers to study WAS syndrome

A pediatric immunologist at The Children's Hospital of Philadelphia collaborated with European gene therapy researchers who achieved marked clinical improvements in two young children with Wiskott-Aldrich syndrome, a very rare but often severe immunodeficiency disorder.

16 Nov 2010

KINARM Assessment Station to help healthcare workers assess patients suffering from brain injuries

A Queen's University neuroscientist is launching a medical tool at the world's largest neuroscience conference in San Diego on Monday, Nov. 15.

16 Nov 2010

Reducing salt intake can enhance health of young adults in future: Research

Cutting back on salt in teenagers' diets by as little as one-half teaspoon, or three grams, a day, could reduce the number of young adults with high blood pressure by 44 to 63 percent, according to new research presented Sunday, Nov. 14 at the American Heart Association's Scientific Sessions 2010 meeting in Chicago.

16 Nov 2010

BiovaxID lymphoma vaccine to be featured at ASH Meeting

Biovest International, Inc. today announced that BiovaxID, Biovest's personalized lymphoma vaccine, will be featured in an oral presentation at the American Society of Hematology (ASH) Annual Meeting on Monday, December 6th in Orlando, Florida.

16 Nov 2010

St. Jude presents results from ASSERT trial for stroke at American Heart Association

St. Jude Medical, Inc., a global medical device company, today announced the results of the ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), a St. Jude Medical sponsored trial conducted by the Population Health Research Institute of McMaster University and Hamilton Health Sciences in Hamilton, Canada.

16 Nov 2010

New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research

A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.

16 Nov 2010

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Fisetin, a naturally occurring compound found in strawberries and other fruits and vegetables, slows the onset of motor problems and delays death in three models of Huntington's disease, according to researchers at the Salk Institute for Biological Studies. The study, published in the online edition of Human Molecular Genetics, sets the stage for further investigations into fisetin's neuroprotective properties in Huntington's and other neurodegenerative conditions.

16 Nov 2010

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).

16 Nov 2010

Review: Mercury likely plays role in development of AD

Mercury likely plays a role in the development of Alzheimer's disease, according to a review of relevant scientific literature published this month in The Journal of Alzheimer's Disease. Dr. Joachim Mutter of Germany, Dr. Richard Deth of the United States, and other esteemed researchers collaborated on the groundbreaking article Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism, which clarifies the need for continuing research to understand the cause of neurological diseases such as Alzheimer's.

16 Nov 2010

Medical Condition News

4SC to present development of resminostat and preclinical drug candidates at EORTC-NCI-AACR symposium

Study finds two-thirds of asthma patients take combined ICS/LABA treatment

Merrion prepares Phase III study for Orazol in breast cancer treatment

Iron in plaque may predict risk of myocardial infarction

Inconsistent food labels contribute to consumer uncertainty about appropriate food intake

Study finds significant variability in CPR quality between day and night

IFPA announces winner of Under the Spotlight Award for psoriasis documentary

Canadian government announces new research initiative on childhood obesity

Handwriting problems in autistic children likely to continue into teenage years: Study

Health researchers to address mental health concerns at world conference

New high-sensitive blood test may help predict risk of heart failure in older people

Children's Hospital pediatric immunologist collaborates with European gene therapy researchers to study WAS syndrome

KINARM Assessment Station to help healthcare workers assess patients suffering from brain injuries

Reducing salt intake can enhance health of young adults in future: Research

BiovaxID lymphoma vaccine to be featured at ASH Meeting

St. Jude presents results from ASSERT trial for stroke at American Heart Association

New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Review: Mercury likely plays role in development of AD

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Latest News